The influence of neonatal aminoglycoside administration on the vestibular organs

• Conditions: Bacterial sepsis of newborn; P36

• Registration Number: DRKS00014184
• Lead Sponsor: MM HNO-Mannheim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-04-04
• Study Completion: 2023-06-29
• Results First Posted: 2024-02-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

treatment with aminoglycoside

Exclusion Criteria

no treatment with aminoglycoside

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary endpoint measures is the vestibular function:<br>The gain and the occurrence of catch-up saccades is analyzed using video-head-impulse test the deviation from the vertical in degrees. (subjective visual vertical)

Secondary Outcome Measures

Name	Time	Method
The secondary endpoint is a one-off evaluation of a questionnaire on the motor development of the children.